Ratings by Credit Suisse (Erin Wright)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/17/2020 | IDEXX Laboratories | IDXX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/4/2020 | IDEXX Laboratories | IDXX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/19/2020 | CVS Health | CVS | Maintain | Neutral (N/A) |
|
Details | ||
| 8/16/2019 | IDEXX Laboratories | IDXX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/22/2019 | McKesson | MCK | New Coverage | Neutral (N/A) |
139.68 (919.26) |
558.12% | Details | |
| 4/30/2019 | Aratana Therapeutics | PETX | Downgrade | Neutral (Outperform) |
4.79 (4.92) |
2.71% | Details | |
| 4/29/2019 | CVS Health | CVS | New Coverage | Neutral (Outperform) |
53.53 (77.92) |
45.56% | Details | |
| 4/2/2019 | Diplomat Pharmacy | DPLO | Maintain | Neutral (N/A) |
|
Details | ||
| 3/13/2019 | Aratana Therapeutics | PETX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/11/2019 | Walgreens Boosts Alliance | WBA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/11/2019 | CVS Health | CVS | Maintain | Outperform (N/A) |
|
Details | ||
| 1/30/2019 | Align Technology | ALGN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/20/2018 | Align Technology | ALGN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/25/2018 | Align Technology | ALGN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/25/2018 | Charles River Labs | CRL | Maintain | Neutral (Neutral) |
|
Details | ||
| 8/21/2018 | Charles River Labs | CRL | Maintain | Neutral (N/A) |
|
Details | ||
| 8/17/2018 | IDEXX Laboratories | IDXX | Maintain | Outperform (N/A) |
|
Details |
